Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer

IMPORTANCE: The variant HSD3B1 (1245C) allele enhances dihydrotestosterone synthesis and predicts resistance to androgen-deprivation therapy (ADT) for biochemically recurrent prostate cancer after prostatectomy and for metastatic disease. Whether this is true after radiotherapy is unknown. OBJECTIVE...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Oncol
Main Authors: Hearn, Jason W. D., Xie, Wanling, Nakabayashi, Mari, Almassi, Nima, Reichard, Chad A., Pomerantz, Mark, Kantoff, Philip W., Sharifi, Nima
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2017
Teme:
Brief Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933377/
https://ncbi.nlm.nih.gov/pubmed/29049492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.3164
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki